MedPath

Patient Navigator Project

Not Applicable
Completed
Conditions
Breast Cancer
Colon Cancer
Interventions
Procedure: Patient Navigation
Procedure: Clinic Staff
Registration Number
NCT00375024
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Brief Summary

Patient Navigation is a Supportive Care Intervention that addresses barriers to quality standard care by providing individualized assistance to patients and families. The NCI is conducting several research programs to test the effectiveness of this approach. The expected outcomes of patient navigation through the cancer care system include:

* Timely, definitive diagnosis following an abnormal test

* Timely treatment following positive diagnosis

* Patient satisfaction with the diagnostic and care system experience

Detailed Description

The goal of our local project is to provide Tampa Bay with a culturally appropriate Patient Navigator Program that will decrease delay in diagnosis and delivery of cancer care in an acceptable and cost-effective manner leading to lower cancer mortality among our underserved populations. We will partner with community health centers in the Tampa Bay area to provide an avenue for patients who have received an abnormal screening for breast and colorectal cancer to easier pilot the course of the healthcare system. The populations served by this program will include African-Americans, Hispanics and rural Whites who are medically underserved due to lack of insurance, documentation issues and a variety of other barriers to health care.

The primary outcome to be tested with this program is the time it takes for patients with an abnormality to receive a definitive diagnosis. Secondary outcomes such as patient satisfaction and cost-effectiveness will also be measured. This program occurs in three phases. In Phase I, the aim is to work closely with our key community partners to conduct formative research for the development of an acceptable, appealing, and appropriate Patient Navigator Program. The aim for Phase II is to conduct a group randomized controlled trial by having participating clinics randomly assigned to an intervention or control clinic. The outcomes from this phase in the project will be assessed through chart reviews, patient satisfaction surveys and other survey methods. In Phase III a comprehensive evaluation on the program will be produced and disseminated nationally.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1267
Inclusion Criteria
  • Receive health care at one of the enrolled clinics
  • Newly diagnosed with breast of colorectal cancer or if they have an abnormality that is suspicious for breast (breast lump, or abnormal mammogram) or colorectal cancer (abnormal colon screening test, blood in bowel movement).
Exclusion Criteria
  • Persons with previous history of breast or colon cancer will be excluded from the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1: Patient NavigatorPatient NavigationPatients will meet with a Patient Navigator regarding their treatment and any related concerns.
2: Without NavigatorClinic StaffPatient will work with existing clinic staff, which does not include a Patient Navigator.
Primary Outcome Measures
NameTimeMethod
Questionnaire Results Regarding Time to DiagnosisIndividual per patient

Time from finding of abnormality to definitive diagnosis

Secondary Outcome Measures
NameTimeMethod
Patient Satisfaction Questionaire ResultsAt end of patient participation
Questionnaire Results Regarding Patient NavigatorsEnd of study

To determine if patient navigators are cost effective

Trial Locations

Locations (1)

H. Lee Moffitt Cancer Center & Research Institute

🇺🇸

Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath